Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 5/20 | 0.45 |
| ▸ | RAB9A | P51151 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | STAT1 | P42224 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21018825 | 0.91 | CLK4 (0.47) | SMN1; SMN2MAPTNPC1RAB9AMEN1 | |
| SCHEMBL21018826 | 0.89 | SMN1; SMN2 (0.46) | SMN1; SMN2MAPTNPC1RAB9AMEN1 | |
| SCHEMBL21019138 | 0.88 | NPC1 (0.44) | SMN1; SMN2MAPTNPC1RAB9AMEN1 | |
| SCHEMBL18909522 | 0.88 | CLK4 (0.42) | SMN1; SMN2MAPTNPC1RAB9AMEN1 | |
| SCHEMBL16614433 | 0.88 | SMN1; SMN2 (0.59) | SMN1; SMN2MAPTNPC1RAB9AMEN1 | |
| SCHEMBL18783443 | 0.88 | SMN1; SMN2 (0.59) | SMN1; SMN2MAPTNPC1RAB9AMEN1 | |
| SCHEMBL16614435 | 0.87 | CLK4 (0.41) | SMN1; SMN2MAPTNPC1RAB9AMEN1 | |
| SCHEMBL21012627 | 0.86 | NOTUM (0.48) | SMN1; SMN2MAPTNPC1RAB9AMEN1 | |
| SCHEMBL25954435 | 0.82 | CLK4 (0.56) | SMN1; SMN2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL19219066 | 0.80 | MAPT (0.58) | SMN1; SMN2MAPTNPC1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190157567-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | DOOSAN CORPORATION (KR) | 2019-05-23 | — | — | US | disclosed |
| WO-2015046982-A2 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | 주식회사 두산 | 2015-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190157567-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | SLC18A3, L1CAM, TMEM109 | SMN1; SMN2 2435/4885MAPT 1370/4885NPC1 646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.